Cold Genesys has raised $22 million in series C funding to advance its oncolytic immunotherapy for bladder cancer and other solid tumors. The biotech is developing the candidate both as a single agent ...

Bladder training is when a person makes a conscious effort to urinate at fixed intervals. The idea is to gradually increase those intervals over time. This could lead to a larger bladder capacity and ...